| Financial Year |
March 31 2022 |
| Monetary Funds |
766,825,201.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
411,626,902.20 |
| Advances to Suppliers |
16,732,556.43 |
| Other Receivables |
1,640,464.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
380,883,806.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,359,728.31 |
| Total Current Assets |
1,605,719,725.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,352,354,476.96 |
| Under-construction Projects |
983,787,093.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
160,487,546.97 |
| R&D expenses |
-- |
| Goodwill |
38,094,835.51 |
| Long-Term Deferred and Prepaid Expenses |
6,643,896.73 |
| Deferred Income Tax Assets |
9,816,817.65 |
| Other Non-Current Assets |
41,152,117.68 |
| Sub-Total of Non-Current Assets |
2,615,603,363.61 |
| Total Assets |
4,221,323,088.73 |
| Short-Term Loans |
500,481,444.46 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,112,215.37 |
| Accounts Payable |
191,122,528.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,967,978.08 |
| Taxes Payable |
17,044,994.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
90,828,247.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
193,048,423.87 |
| Other Current Liabilities |
215,148.51 |
| Sub-Total of Current Liabilities |
1,025,475,968.65 |
| Long-term Loans |
369,679,565.25 |
| Bonds Payable |
517,790,119.81 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
41,384,594.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
959,931,623.91 |
| Total Liabilities |
1,985,407,592.56 |
| Paid-In Capital(Or Share Stock) |
410,021,307.00 |
| Capital Surplus |
506,277,353.88 |
| Surplus Reserve |
132,257,349.32 |
| LESS:Treasury Stock |
56,380,740.00 |
| Undistributed Profits |
1,138,719,323.03 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,235,915,496.17 |
| Owner's Equity（Stockholder's Equity） |
2,235,915,496.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,221,323,088.73 |
